Wealthink AI-Innovation Capital Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Wealthink AI-Innovation Capital.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Capital Markets earnings growth | 22.1% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | None |
Last updated | n/a |
Recent future growth updates
No updates
Recent updates
What Kind Of Investors Own Most Of Wealthking Investments Limited (HKG:1140)?
Mar 18Wealthking Investments' (HKG:1140) Shareholders Are Down 71% On Their Shares
Feb 11Zhiwei Liu Is The Executive Chairman of the Board of Wealthking Investments Limited (HKG:1140) And They Just Picked Up 65% More Shares
Jan 07What Type Of Shareholders Make Up OP Financial Limited's (HKG:1140) Share Registry?
Dec 15In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Wealthink AI-Innovation Capital has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
3/31/2024 | 308 | 54 | -49 | -47 | N/A |
12/31/2023 | 281 | 5 | -51 | -48 | N/A |
9/30/2023 | 255 | -44 | -53 | -49 | N/A |
6/30/2023 | 224 | 51 | -76 | -73 | N/A |
3/31/2023 | 193 | 146 | -100 | -96 | N/A |
12/31/2022 | 162 | 192 | 14 | 13 | N/A |
9/30/2022 | 131 | 238 | 127 | 123 | N/A |
6/30/2022 | 113 | 229 | 48 | 47 | N/A |
3/31/2022 | 95 | 221 | -31 | -28 | N/A |
12/31/2021 | 105 | 183 | -135 | -130 | N/A |
9/30/2021 | 114 | 144 | -238 | -231 | N/A |
6/30/2021 | 113 | 258 | -146 | -143 | N/A |
3/31/2021 | 112 | 373 | -54 | -54 | N/A |
12/31/2020 | 118 | -420 | -80 | -75 | N/A |
9/30/2020 | 124 | -1,213 | -106 | -96 | N/A |
6/30/2020 | 153 | -1,293 | -109 | -96 | N/A |
3/31/2020 | 182 | -1,373 | -113 | -95 | N/A |
12/31/2019 | 199 | -407 | -45 | -30 | N/A |
9/30/2019 | 216 | 558 | 22 | 34 | N/A |
6/30/2019 | 230 | 407 | -61 | -53 | N/A |
3/31/2019 | 245 | 257 | -145 | -140 | N/A |
12/31/2018 | 231 | 117 | -230 | -227 | N/A |
9/30/2018 | 217 | -23 | -315 | -313 | N/A |
6/30/2018 | 171 | 60 | -264 | -264 | N/A |
3/31/2018 | 125 | 143 | -214 | -214 | N/A |
12/31/2017 | 112 | 221 | N/A | 8 | N/A |
9/30/2017 | 98 | 298 | N/A | 231 | N/A |
6/30/2017 | 100 | 243 | N/A | 136 | N/A |
3/31/2017 | 102 | 188 | N/A | 41 | N/A |
12/31/2016 | 82 | 105 | N/A | -214 | N/A |
9/30/2016 | 63 | 21 | N/A | -469 | N/A |
6/30/2016 | 46 | 33 | N/A | -264 | N/A |
3/31/2016 | 29 | 44 | N/A | -59 | N/A |
12/31/2015 | 27 | 38 | N/A | -16 | N/A |
9/30/2015 | 24 | 31 | N/A | 28 | N/A |
6/30/2015 | 28 | 14 | N/A | 45 | N/A |
3/31/2015 | 32 | -3 | N/A | 62 | N/A |
12/31/2014 | 36 | 14 | N/A | 93 | N/A |
9/30/2014 | 40 | 31 | N/A | 123 | N/A |
6/30/2014 | 36 | 39 | N/A | 52 | N/A |
3/31/2014 | 31 | 47 | N/A | -19 | N/A |
12/31/2013 | 28 | 36 | N/A | 105 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if 1140's forecast earnings growth is above the savings rate (2.3%).
Earnings vs Market: Insufficient data to determine if 1140's earnings are forecast to grow faster than the Hong Kong market
High Growth Earnings: Insufficient data to determine if 1140's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if 1140's revenue is forecast to grow faster than the Hong Kong market.
High Growth Revenue: Insufficient data to determine if 1140's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 1140's Return on Equity is forecast to be high in 3 years time